Bangkok Lab and Cosmetic PCLBKK:BLC +1.02%63 Altman Z-Score is 3.13 as of Jul. 07, 2026, which is 30% below its 10-year median of 4.44. GuruFocus rates BKK:BLC with a GF Score™ of 63/100 and a GF Value™ of ฿5.12 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,930 Consumer Packaged Goods companies, Bangkok Lab and Cosmetic PCL ranks better than 54.66% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 3.12 is strong.
Bangkok Lab and Cosmetic PCL has a Altman Z-Score of 3.13, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Bangkok Lab and Cosmetic PCL's Altman Z-Score or its related term are showing as below:
BKK:BLC'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.1 Med: 4.44 Max: 5.28
Current: 3.12
During the past 5 years, Bangkok Lab and Cosmetic PCL's highest Altman Z-Score was 5.28. The lowest was 3.10. And the median was 4.44.
Bangkok Lab and Cosmetic PCL (BKK:BLC) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:BLC vs PG, CL, KVUE: Altman Z-Score Comparison
For the Household & Personal Products subindustry, Bangkok Lab and Cosmetic PCL's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Lab and Cosmetic PCL Altman Z-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bangkok Lab and Cosmetic PCL's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Bangkok Lab and Cosmetic PCL's Altman Z-Score falls into.
Bangkok Lab and Cosmetic PCL Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Bangkok Lab and Cosmetic PCL (BKK:BLC) has a Altman Z-Score of 3.13 as of Jul. 07, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. This is 30% below median its historical median of 4.44. Over the past decade, Bangkok Lab and Cosmetic PCL's Altman Z-Score has ranged from 3.10 to 5.28. According to the industry distribution chart, Bangkok Lab and Cosmetic PCL ranks #875 out of 1930 companies in the Consumer Packaged Goods industry, placing it in the top 45.3%.
Is Bangkok Lab and Cosmetic PCL's Altman Z-Score too high?
Bangkok Lab and Cosmetic PCL's current Altman Z-Score of 3.13 is 30% below median its 10-year median of 4.44. Over the past 10 years, this metric has ranged from a low of 3.10 to a high of 5.28. The Consumer Packaged Goods industry median Altman Z-Score is 2.86. Bangkok Lab and Cosmetic PCL's value of 3.13 is 9.4% above this industry median. Based on the distribution chart, Bangkok Lab and Cosmetic PCL ranks #875 out of 1930 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Bangkok Lab and Cosmetic PCL has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Lab and Cosmetic PCL's Altman Z-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Bangkok Lab and Cosmetic PCL ranks #875 out of 1930 companies for Altman Z-Score. This puts Bangkok Lab and Cosmetic PCL in the upper half of its industry. The industry median Altman Z-Score is 2.86. Bangkok Lab and Cosmetic PCL's value of 3.13 is 9.4% above this benchmark. Historically, Bangkok Lab and Cosmetic PCL's own Altman Z-Score has ranged from 3.10 to 5.28 over the past decade. While the company's 10-year median is 4.44 vs. the industry median of 2.86, Bangkok Lab and Cosmetic PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Consumer Packaged Goods company?
The median Altman Z-Score among Consumer Packaged Goods companies is 2.86, based on 1,930 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Lab and Cosmetic PCL's current Altman Z-Score of 3.13 is 9.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. For the Consumer Packaged Goods industry, the median Altman Z-Score is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Lab and Cosmetic PCL's current Altman Z-Score is 3.13, which is 30% below median its own 10-year median of 4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Lab and Cosmetic PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL (BKK:BLC) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿5.12, compared to a current price of ฿3.96 — trading 22.7% below its estimated fair value. The current Altman Z-Score is 3.13, which is 30% below median its 10-year median of 4.44 and 9.4% above the Consumer Packaged Goods industry median of 2.86. Bangkok Lab and Cosmetic PCL's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Bangkok Lab and Cosmetic PCL (BKK:BLC), the current Altman Z-Score is 3.13 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Lab and Cosmetic PCL (BKK:BLC) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL stock appears to be undervalued.
The current stock price of ฿3.96 is trading 22.7% below its estimated GF Value™ of ฿5.12.
GuruFocus considers Bangkok Lab and Cosmetic PCL to be Modestly Undervalued.
Key valuation signals for BKK:BLC:
Altman Z-Score: 3.13 (30% below median its 10-year median of 4.44)
GF Value™: ฿5.12 vs. price of ฿3.96 (22.7% below fair value)
Industry Position: 9.4% above the Consumer Packaged Goods median (#875 of 1930)
No single metric tells the full story. See the BKK:BLC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. The principal activities of the Group are the manufacturing and distributing of pharmaceuticals and medicinal chemical products for human and animal It operates in a single line of business, namely pharmaceuticals and medicinal chemical products, The Group derives revenue from sales of goods and rendering of services.
63GF Score
Get the complete analysis for BKK:BLC
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BLC has been successfully added to your 
